Cafepharma Today

September 22 2017 - Why Gilead Sciences is borrowing $3 billion

Why cash-rich Gilead is borrowing $3 billion, pharma execs wary of value-based contracts, Express Scripts backs new pricing models for CAR-T, and more - scroll down for the latest news

Embed from Getty Images

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

Biotech: The Big Payoff
Seeking Alpha
Sunday, September 24, 2017 - 10:34am
tags:
biotech, Gilead Sciences, M&A
Generics Industry Calls FDA Draft Guidance on Priority Reviews 'Basically Inoperable'
RAPS.org
Sunday, September 24, 2017 - 10:25am
tags:
generics, FDA, priority review
3 Monster Biotech Stocks in the Making
Motley Fool
Sunday, September 24, 2017 - 10:24am
tags:
biotech, Exelixis, Incyte, Vertex Pharmaceuticals
4 Ways to Create Adherence Programs That Lead to Long-Term Change
Medical Marketing and Media
Sunday, September 24, 2017 - 10:20am
tags:
patients, patient adherence, adherence programs
CVS to limit opioid prescriptions to 7 days
Chicago Tribune, IL
Saturday, September 23, 2017 - 10:07am
tags:
CVS, opioids, opioid crisis
AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo
Fierce Biotech
Saturday, September 23, 2017 - 10:02am
tags:
AbbVie, Bristol-Myers Squibb, Opdivo, ABBV-399, antibody-drug conjugate, non-small cell lung cancer
FDA spurns J&J’s troubled rheumatoid arthritis drug sirukumab
Endpoints
Saturday, September 23, 2017 - 10:01am
tags:
FDA, JNJ, rheumatoid arthritis, sirukumab
More Than $500K in Prizes on the Line for Four Startups
Qmed
Saturday, September 23, 2017 - 9:59am
tags:
devices, Abreos Biosciences, Veritope, Allotrope, ureter injuries, Day Zero Diagnostics, diagnostics, antibiotic resistance, Selio Medical, pneumothorax
J&J Alerted to Risk of Asbestos in Talc in '70s, Files Show
Newsmax
Saturday, September 23, 2017 - 9:57am
tags:
JNJ
Boston Scientific's New Defibrillators Really Are Smarter
Qmed
Saturday, September 23, 2017 - 9:56am
tags:
Boston Scientific, defibrillators, devices, HeartLogic
Women in big pharma boards: still under-represented
GoInPharma
Saturday, September 23, 2017 - 9:54am
tags:
Big Pharma, women
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?
Motley Fool
Friday, September 22, 2017 - 11:25am
tags:
Gilead Sciences, taxes, Kite Pharma, M&A
Two years on, Allergan’s $1.7B NASH drug still looks weak — at best
Endpoints
Friday, September 22, 2017 - 11:16am
tags:
Allergan, NASH, Novartis, Cenicriviroc
Pharma executives wary of value-based deals, but see the potential benefits: PwC
Fierce Pharma
Friday, September 22, 2017 - 11:13am
tags:
value-based contracts, Amgen, Novartis, Sanofi, Merck
GSK vets Witty and Slaoui find new roles in biotech as the great migration continues
Endpoints
Friday, September 22, 2017 - 11:11am
tags:
GSK, Andrew Witty, Moncef Slaoui, biotech
Versartis growth hormone drug fails key study, shares sink
Yahoo/Reuters
Friday, September 22, 2017 - 9:59am
tags:
Versartis, growth hormone, clinical trials, somavaratan
AbbVie’s top execs paint a rosy pic of the mega-blockbuster future looming for Humira and PhIII drugs
Endpoints
Friday, September 22, 2017 - 9:19am
tags:
AbbVie, Humira, Rick Gonzalez
FDA Warns Doctors After 19 Deaths on Intercept Liver Drug
Bloomberg
Friday, September 22, 2017 - 9:16am
tags:
FDA, Intercept Pharma, Ocaliva, liver disease
Express Scripts' Miller Backs New Pricing Models for CAR-T
BioCentury
Friday, September 22, 2017 - 9:13am
tags:
Express Scripts, drug pricing, CAR-T, gene therapy, Kymriah
House committee wants to know a lot more about the cyberattack that damaged Merck
Endpoints
Friday, September 22, 2017 - 9:11am
tags:
Merck, cybersecurity, cyberattack
WHO raises alarm on lack of new antibiotics
GoInPharma
Friday, September 22, 2017 - 9:09am
tags:
WHO, antibiotics, drug development
A China biotech unicorn scores big with $150M-plus IPO on Nasdaq, stock rockets up
Endpoints
Friday, September 22, 2017 - 9:07am
tags:
China, biotech, IPOs, NASDAQ, Zai Labs
Public Citizen Sues FDA Over OTC Drug Risks
RAPS.org
Friday, September 22, 2017 - 9:04am
tags:
FDA, Public Citizen, OTC
Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst
Fierce Pharma
Thursday, September 21, 2017 - 10:18pm
tags:
Pfizer, Ibrance, breast cancer
New pharma CEOs to face payer, pricing challenges
Medical Marketing and Media
Thursday, September 21, 2017 - 10:15pm
tags:
Pharma CEOs, Novartis, Teva Pharmaceutical, Kåre Schultz, Vasant Narasimham, payers, drug pricing
Johnson & Johnson challenges $417M talc verdict, its largest defeat yet
Fierce Pharma
Thursday, September 21, 2017 - 10:12pm
tags:
JNJ
Fortune's Most Powerful Women list stresses gender gap in pharma
BioPharma Dive
Thursday, September 21, 2017 - 10:12pm
tags:
Fortune, women, gender gap
Alzheimer's drug development just as challenging as ever
BioPharma Dive
Thursday, September 21, 2017 - 10:11pm
tags:
drug development, Alzheimer's disease, PhRMA
Duchenne muscular dystrophy
Motley Fool
Thursday, September 21, 2017 - 10:10pm
tags:
Duchenne Muscular Dystrophy, PTC Therapeutics, Translarna, Axovant Sciences, Alzheimer's disease, NASH, Gilead Sciences
Pfizer hits a snag in bid to jump-start Sutent's flagging kidney cancer sales
Fierce Pharma
Thursday, September 21, 2017 - 10:02pm
tags:
Pfizer, Sutent, kidney cancer

Latest Pharmagather Articles

How Data Science & Network Analytics Can Help Pharma Shift from Brand Centricity to Customer Centricity
pharmexec marketing
How Data Science & Network Analytics Can Help Pharma Shift from Brand Centricity to Customer Centricity
pharmexec marketing
How Data Science and Network Analytics Can Help Pharma Brands Shift from Brand Centricity to Customer Centricity
pharmexec marketing
The Blind Watchmaker’s Workshop
In the Pipeline
Weekly Roundup 9.22.17
eye on fda
Short Chemistry Topics
In the Pipeline
The Supply Chain: What Price Patient Centricity?
pharmexec technology
Drug Serialization for DSCSA Compliance Benefits Everyone
pharmexec technology
Drug Serialization for DSCSA Compliance Benefits Everyone
pharmexec r&d

Latest CP Wire Articles

Fewer pharma job cuts so far in 2017
How Are Whistleblowers Paid
Proove Biosciences Responds to News About FBI Raid
Tips for Your Next Job Interview
UroToday.com, Leading Urology Reference Site, Launches a New Clinical Trials Portal
Physician-Rep Conversation - A Lesson From Cafepharma
MedReps Survey Reveals Best Places to Work in Medical Sales in 2017 (inc. infographic)
Using Real World Evidence to Drive Affordability of Specialty Drugs
Novartis Social Media Network for Patients - Is This a Good Idea
Risk on the Front Line: Tips for Managing Sales Force Liability
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

Arbutus Presents HBV Data at Upcoming Scientific Conferences
Friday, September 22, 2017 - 4:53pm
Abeona Therapeutics Announces Upcoming Conference Participation
Friday, September 22, 2017 - 8:45am
ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology
Thursday, September 21, 2017 - 7:05am
ProQR to Present at Two Investor Conferences in September
Thursday, September 21, 2017 - 7:00am
Oxygen Concentrators and Cylinders Market worth over $4.5 billion by 2024: Global Market Insights, Inc.
Thursday, September 21, 2017 - 7:00am
BioCryst’s RAPIVAB® (peramivir injection) Receives FDA Approval for a Pediatric Indication
Thursday, September 21, 2017 - 6:00am
Amarin to Present at Cantor Global Healthcare Conference
Wednesday, September 20, 2017 - 4:30pm
Arbutus’ LNP Licensee Alnylam Announces Positive Phase 3 Results for LNP-Enabled Patisiran Program
Wednesday, September 20, 2017 - 12:22pm
Lightstone Ventures Closes New Life Sciences Fund at $250 Million
Wednesday, September 20, 2017 - 7:27am
Achillion to Present at the 2017 Leerink Partners Rare Disease Roundtable Series
Wednesday, September 20, 2017 - 6:05am

Breaking Healthcare News - powered by Seeking Alpha

Maine's Collins puts another nail in coffin of Obamacare repeal
Sunday, September 24, 2017 - 11:56am
Stocks to Watch Next Week
Saturday, September 23, 2017 - 9:49am
FDA rejects Allergan's application for expanded use of antipsychotic med Vraylar
Friday, September 22, 2017 - 5:01pm
FDA approves Agilent's Keytruda companion diagnostic test for gastric cancer
Friday, September 22, 2017 - 4:51pm
Rennova to reverse split shares 1:15 on October 5
Friday, September 22, 2017 - 4:45pm
Atossa files for $50M mixed shelf offering
Friday, September 22, 2017 - 4:32pm
FDA rejects J&J's marketing application for RA med sirukumab, more safety data needed
Friday, September 22, 2017 - 4:27pm
Valeritas inks $20M stock purchase agreement with Aspire Capital
Friday, September 22, 2017 - 4:14pm
Novelion unit Aegerion to admit guilt and pay $36M to settle Juxtapid case
Friday, September 22, 2017 - 4:07pm
MabVax raises $1.25M in direct offering; shares down 12%
Friday, September 22, 2017 - 3:43pm

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.